2,2',3,3',4,4'-hexahydroxy-1,1'-biphenyl-6,6'-dimethanol dimethyl ether has been researched along with Hyperglycemia in 1 studies
2,2',3,3',4,4'-hexahydroxy-1,1'-biphenyl-6,6'-dimethanol dimethyl ether: potent inhibitor of protein kinase C; structure given in first source
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Venugopal, SK | 1 |
| Devaraj, S | 1 |
| Yang, T | 1 |
| Jialal, I | 1 |
1 other study available for 2,2',3,3',4,4'-hexahydroxy-1,1'-biphenyl-6,6'-dimethanol dimethyl ether and Hyperglycemia
| Article | Year |
|---|---|
Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha.
Topics: Acetophenones; alpha-Tocopherol; Antioxidants; Biphenyl Compounds; Cell Line; Ellagic Acid; Enzyme A | 2002 |